usdaed

Back in May, the drama played out again-shares nose-dived 6.2% after the management politely refused to hand out a full-year roadmap, citing macroeconomic fog and the semiconductor sector’s shivers. Now, add another layer of disappointment: Q1 results merely matched expectations-$1.05 billion in revenue, a tidy 12% lift, but just enough to keep the lights on. Earnings per share? A modest decline from $0.40 to $0.35. All in the context of a sharp increase in R&D-up 48%, throwing money into the abyss-$440 million like an offering to the silicon gods, hoping for some divine intervention down the line. Some investors looked at the rising expenses and saw red-what’s the point of funding research when the stock’s bleeding out? But that’s the reckless, beautiful gamble-because Arm, in its madness, might just be manufacturing the seeds of its own resurrection.

See, the market’s irrational. Some days it’s like a happy drunk at a wedding, stumbling in every direction, while on other days it’s eerily sober, calculating every move. But dividends? They’re the calm in the chaos. They keep paying out, quarter after quarter, no matter what the stock gods are doing. That’s a kind of relief. And when you want to take a bit of the guesswork out of investing, it’s not a bad idea to look at a dividend-focused exchange-traded fund (ETF). With $100 to spare, the Schwab U.S. Dividend Equity ETF (SCHD) might be worth your consideration. Why? Let’s unpack it.

Indeed, the market is aflutter-showcasing not just a smattering, but a symphony of stablecoins-over ten now boasting market caps surpassing $450 million. Investors, caught in the glittering allure, must peer beyond the shimmering surface and consider the stark, unromantic truth: these coins are tethered to the dollar, unwavering, unyielding-ceaselessly worth one dollar. The immortal phrase echoes, regardless of popularity or utility, “a dollar is a dollar.”

This incredible transformation owes itself, my dear reader, to the bewitching enchantment of artificial intelligence (AI) that has swirled through the market and entangled the minds of the industrious and the greedy alike.

The answer, dear reader, is as clear as a pilot’s view of the ground during a forced landing: there’s still plenty of fuel in the tank for growth. Why? Because Archer isn’t just selling eVTOLs; they’re selling the idea that you’ll own a personal flying car by 2026. Cha-ching!

Few outside the industry can claim familiarity with Rollins or Rentokil. Rollins, with its familiar brands such as Orkin and Critter Control, dominates much of North America, generating about $3.4 billion in revenue for 2024. Yet, despite its size, it remains a regional player, bound by its origins and limited scope.